Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jun 28, 2022; 28(24): 2705-2732
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2705
Table 2 Clinicopathological features of the early-stage colon cancer patients enrolled in this study, n (%)
VariableTotal (n = 125)Training set (n = 75)Test set (n = 50)
Age (yr)69 (range, 48-94)68 (range, 51-94)70 (range, 48-88)
Sex
Male66 (52.8)39 (52.0)27 (54.0)
Female59 (47.2)36 (48.0)23 (46.0)
Serum CEA (≥ 5 ng/mL)
Positive37 (29.6)21 (28.0)16 (32.0)
Negative88 (70.4)54 (72.0)34 (68.0)
FIT (≥ 200 ng/mL)
Positive78 (62.4)48 (64.0)30 (60.0)
Negative47 (37.6)27 (36.0)20 (40.0)
Tumor site
Proximal64 (51.2)36 (48.0)28 (56.0)
Distal61 (48.8)39 (52.0)22 (44.0)
TNM stage
I47 (37.6)30 (40.0)17 (34.0)
II78 (62.4)45 (60.0)33 (66.0)
T stage
T1-371 (56.8)44 (58.7)27 (54.0)
T454 (43.2)31 (41.3)23 (46.0)
Histological differentiation
Well/moderately98 (78.4)60 (80.0)38 (76.0)
Poorly27 (21.6)15 (20.0)12 (24.0)